What is the generic name?

IBRITUMOMAB TIUXETAN

What is the Trade Name for IBRITUMOMAB TIUXETAN?

Zevalin

What are the Indications for IBRITUMOMAB TIUXETAN?

• 1 INDICATIONS AND USAGE Zevalin is a CD20-directed radiotherapeutic antibody administered as part of the Zevalin therapeutic regimen indicated for the treatment of adult patients with: ‚Ä¢ relapsed or refractory, low-grade or follicular B-cell non-Hodgkin’s lymphoma (NHL) ( 1.1 ). ‚Ä¢ previously untreated follicular NHL who achieve a partial or complete response to first-line chemotherapy ( 1.2 ). 1.1 Relapsed or Refractory, Low-grade or Follicular NHL Zevalin is indicated for the treatment of adult patients with relapsed or refractory, low-grade or follicular B-cell non-Hodgkin’s lymphoma (NHL). 1.2 Previously Untreated Follicular NHL Zevalin is indicated for the treatment of previously untreated follicular NHL in adult patients who achieve a partial or complete response to first-line chemotherapy.

References: https://open.fda.gov/